A meta-analysis of the ARTS, ARTS- HF, and ARTS- HF Japan trials by Pei et al. [30] showed that finerenone demonstrated a dose-dependent reduction in NT-proBNP levels, UACR, and other relevant biochemical markers. This evidence concerns the gene NPPB and hydrops fetalis.